The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa

Nav

General Info

Geography

Nigeria (NGA)

South Africa (ZAF)

Coverage type

Country

Time period covered

01/2011 - 12/2012

Data type

Scientific literature

Keywords

Antiretroviral therapy, HIV and AIDS, HIV transmission, Health care costs, Health care economics, Health care expenditures

Citation

Authors

Schneider K, Nwizu C, Kaplan R, Anderson J, Wilson DP, Emery S, Cooper DA, Boyd MA

Journal

PLoS One

Volume

Issue

Pages

e54435

Publication year

2013

Suggested citation

Schneider K, Nwizu C, Kaplan R, Anderson J, Wilson DP, Emery S, Cooper DA, Boyd MA. The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa. PLoS One. 2013; 8(2): e54435.

DOI

10.1371/journal.pone.0054435

PMID

23457450

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa

Nav